Panagiotis Chatzistavridis is an Anaesthesiology resident at the General Hospital of Athens “G. Gennimatas”, Greece, and a PhD candidate at the National and Kapodistrian University of Athens (Aretaieio Hospital). His doctoral research focuses on opioid-free anaesthesia in bariatric surgery. He holds an MSc in Clinical Pharmacology from the Laboratory of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, where he also works as a Scientific Collaborator. His research interests include pharmacokinetics and pharmacodynamics, target-controlled infusion and total intravenous anaesthesia, neuroanaesthesia, oncologic anaesthesia, and clinical trial methodology. He has served as Principal Investigator and Sub-Investigator on more than 15 Phase II–IV multicentre clinical trials and is ICH-GCP certified. He is also active in medical education and simulation-based training.
Panagiotis Chatzistavridis is an Anaesthesiology resident at the General Hospital of Athens “G. Gennimatas”, Greece, and a PhD candidate at the National and Kapodistrian University of Athens (Aretaieio Hospital). His doctoral research focuses on opioid-free anaesthesia in bariatric surgery. He holds an MSc in Clinical Pharmacology from the Laboratory of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, where he also works as a Scientific Collaborator. His research interests include pharmacokinetics and pharmacodynamics, target-controlled infusion and total intravenous anaesthesia, neuroanaesthesia, oncologic anaesthesia, and clinical trial methodology. He has served as Principal Investigator and Sub-Investigator on more than 15 Phase II–IV multicentre clinical trials and is ICH-GCP certified. He is also active in medical education and simulation-based training.